Daniel J. Lippis, CVP, JAPAC at Edwards Lifesciences Corp (EW), sold 1,714 shares at $92.34 ($158K) on 2024-04-09, disclosed to the SEC on 2024-04-09.
Scheduled sale ($158k) by CVP, JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.34 | 857 | $79K | 50.0% |
| 2 | $92.34 | 857 | $79K | 50.0% |
| Total | $92.34 avg | 1,714 | $158K | 100% |
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |